Clinicopathological Characteristics of RET Rearranged Lung Cancer in European Patients.

• Michels S Center for Integrated Oncology Köln Bonn, Cologne, Germany; Lung Cancer Group Cologne, Department I for Internal Medicine, University Hospital of Cologne, Cologne, Germany; Network Genomic Medicine, Cologne, Germany.
• Scheel AH Network Genomic Medicine, Cologne, Germany; Institute of Pathology, University Hospital of Cologne, Cologne, Germany.
• Scheffler M Center for Integrated Oncology Köln Bonn, Cologne, Germany; Lung Cancer Group Cologne, Department I for Internal Medicine, University Hospital of Cologne, Cologne, Germany; Network Genomic Medicine, Cologne, Germany.
• Schultheis AM Network Genomic Medicine, Cologne, Germany; Institute of Pathology, University Hospital of Cologne, Cologne, Germany.
• Gautschi O Department for Medical Oncology, Lucerne Cantonal Hospital, Lucerne, Switzerland.
• Aebersold F Institute of Pathology, Lucerne Cantonal Hospital, Lucerne, Switzerland.
• Diebold J Institute of Pathology, Lucerne Cantonal Hospital, Lucerne, Switzerland.
• Pall G Department for Internal Medicine, Haematology and Oncology, University Hospital Innsbruck, Innsbruck, Austria.
• Rothschild S Department for Oncology, University Hospital Basel, Basel, Switzerland.
• Bubendorf L Department for Cytopathology, University Hospital Basel, Basel, Switzerland.
• Hartmann W Gerhard-Domagk-Institute of Pathology, University Hospital of Münster, Münster, Germany.
• Heukamp L Network Genomic Medicine, Cologne, Germany; Institute of Pathology, University Hospital of Cologne, Cologne, Germany.
• Schildhaus HU Institute of Pathology, University Hospital of Göttigen, Göttingen, Germany.
• Fassunke J Network Genomic Medicine, Cologne, Germany; Institute of Pathology, University Hospital of Cologne, Cologne, Germany.
• Ihle MA Network Genomic Medicine, Cologne, Germany; Institute of Pathology, University Hospital of Cologne, Cologne, Germany.
• Künstlinger H Network Genomic Medicine, Cologne, Germany; Institute of Pathology, University Hospital of Cologne, Cologne, Germany.
• Heydt C Network Genomic Medicine, Cologne, Germany; Institute of Pathology, University Hospital of Cologne, Cologne, Germany.
• Fischer R Center for Integrated Oncology Köln Bonn, Cologne, Germany; Lung Cancer Group Cologne, Department I for Internal Medicine, University Hospital of Cologne, Cologne, Germany; Network Genomic Medicine, Cologne, Germany.
• Nogovà L Center for Integrated Oncology Köln Bonn, Cologne, Germany; Lung Cancer Group Cologne, Department I for Internal Medicine, University Hospital of Cologne, Cologne, Germany; Network Genomic Medicine, Cologne, Germany.
• Mattonet C Center for Integrated Oncology Köln Bonn, Cologne, Germany; Lung Cancer Group Cologne, Department I for Internal Medicine, University Hospital of Cologne, Cologne, Germany; Network Genomic Medicine, Cologne, Germany.
• Hein R Institute of Medical Statistics, Informatics and Epidemiology, University Hospital of Cologne, Cologne, Germany.
• Adams A Institute of Medical Statistics, Informatics and Epidemiology, University Hospital of Cologne, Cologne, Germany.
• Gerigk U Thoracic Centre, Malteser Hospital Bonn/Rhein-Sieg, Bonn, Germany.
• Schulte W Departent for Pulmonology Cardiology and Allergology, Johanniter Hospital, Bonn, Germany.
• Lüders H Evangelic Lung Clinic Berlin, Department of Pneumology, Berlin, Germany.
• Grohé C Evangelic Lung Clinic Berlin, Department of Pneumology, Berlin, Germany.
• Graeven U Department for Hematology, Oncology and Gastroenterology, Maria Hilf Hospital Mönchengladbach, Mönchengladbach, Germany.
• Müller-Naendrup C Private Practice for Oncology, Medical Centre II (Martinus Höfe), Olpe, Germany.
• Draube A Department for Internal Medicine, St. Vinzenz Hospital Cologne, Cologne, Germany.
• Kambartel KO Department for Pulmonology and Allergology, Bethanien Hospital Moers, Moers, Germany.
• Krüger S Department for Pulmonology/Allergology/Sleep Medicine and Respiratory Care, Florence-Nightingale-Hospital, Düsseldorf, Germany.
• Schulze-Olden S Department for Pulmonology/Allergology/Sleep Medicine and Respiratory Care, Florence-Nightingale-Hospital, Düsseldorf, Germany.
• Serke M Department for Pulmonology and Thoracic Oncology, Lung Clinic Hemer, Hemer, Germany.
• Engel-Riedel W Lung Clinic Merheim, Hospitals of Cologne, Cologne, Germany.
• Kaminsky B Clinic for Pulmonology and Allergology, Bethanien Hospital, Solingen, Germany.
• Randerath W Clinic for Pulmonology and Allergology, Bethanien Hospital, Solingen, Germany.
• Merkelbach-Bruse S Network Genomic Medicine, Cologne, Germany; Institute of Pathology, University Hospital of Cologne, Cologne, Germany.
• Büttner R Network Genomic Medicine, Cologne, Germany; Institute of Pathology, University Hospital of Cologne, Cologne, Germany.
• Wolf J Center for Integrated Oncology Köln Bonn, Cologne, Germany; Lung Cancer Group Cologne, Department I for Internal Medicine, University Hospital of Cologne, Cologne, Germany; Network Genomic Medicine, Cologne, Germany. Electronic address: juergen.wolf@uk-koeln.de.

Show more…

Adenocarcinoma

Clinicopathological characteristics

NSCLC

RET rearrangement

Smoking history

TP53

Adenocarcinoma

Adult

Aged

Aged, 80 and over

Biomarkers, Tumor

Carcinoma, Squamous Cell

Europe

Female

Follow-Up Studies

Gene Rearrangement

Humans

In Situ Hybridization, Fluorescence

Lung Neoplasms

Male

Middle Aged

Neoplasm Staging

Oncogene Proteins, Fusion

Prognosis

Proto-Oncogene Proteins c-ret

Retrospective Studies